AbCellera Biologics Inc.
11.05USD
-0.3900 (-3.41%)
Fetching financial statements from SEC filings…
| In $M except per-share | Q2 FY26 | Q1 FY26 | Q4 FY25* | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24* | Q3 FY24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 4 | 8 | 45 | 9 | 17 | 4 | 5 | 7 |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Operating Income | -63 | -58 | -29 | -76 | -50 | -63 | -73 | -94 |
| Net Income | -55 | -43 | -9 | -57 | -35 | -46 | -34 | -51 |
| EPS (Diluted) | $-0.18 | $-0.14 | $-0.03 | $-0.19 | $-0.12 | $-0.15 | $-0.11 | $-0.17 |
* Derived period (computed from FY minus reported quarters). Source: SEC filings (EDGAR)